Myasthenia gravis: discontinuation of long-term azathioprine. 1988

M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
February 1990, Postgraduate medical journal,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
March 1985, Annals of neurology,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
October 1999, Der Nervenarzt,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
October 1987, Lancet (London, England),
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
June 1972, Lancet (London, England),
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
September 2016, Muscle & nerve,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
September 1987, Lancet (London, England),
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
May 2000, Annals of neurology,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
May 1984, Postgraduate medical journal,
M Michels, and R Hohlfeld, and H P Hartung, and K Heininger, and U A Besinger, and K V Toyka
November 1986, Neurology,
Copied contents to your clipboard!